Recombinant Rabbit Monoclonal Anti- PIN1 antibody

Quantity:
Add to cart
Price:
$ 0.00

  


Catalog#  BRM1129-2


Lot # Check on the product label


Size 100 μl


Isotype IgG


Host Rabbit


Reactivity 

Human, mouse, rat


Immunogen Recombinant protein of mouse Pin1.


Clone ID  3Z3


Synonyms DOD; UBL5, peptidylprolyl cis/trans isomerase; NIMA-interacting 1


Content Supplied in 50mM Tris-Glycine(pH 7.4), 0.15M NaCl, 40%Glycerol, 0.01% New type preservative N and 0.05% BSA.


Recommend Application

Western Blot, WB (1:1000)

Immunocytochemistry, ICC/IF (1:100)

Immunoprecipitation, IP (1:20-1:50)

Flow Cytometry, Flow-Cyt (1:200-1:500)

Other applications have not been tested.

The optimal dilutions should be determined by end user.


Storage Instruction 

Ship at 2-8°C, when receipt, aliquot and store at -20°C for one year.

Avoid repeated freeze and thaw cycles.


Background

Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 is an enzyme that in humans is encoded by the PIN1 gene. Pin 1, or peptidyl-prolyl cis/trans isomerase (PPIase), isomerizes only phospho-Serine/Threonine-Proline motifs. The enzyme binds to a subset of proteins and thus plays a role as a post phosphorylation control in regulating protein function. Studies have shown that the deregulation of Pin1 may play a pivotal role in various diseases. Notably, the up-regulation of Pin1 is implicated in certain cancers, and the down-regulation of Pin1 is implicated in Alzheimer's disease. Inhibitors of Pin1 may have therapeutic implications for cancer and immune disorders.


Reference

1. da Costa KS, Galúcio JM, de Jesus DA, Gomes GC, Lima e Lima AH, Taube PS, dos Santos AM, Lameira J (2019-10-25). "Targeting Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1: A Structure-based Virtual Screening Approach to Find Novel Inhibitors". Current Computer-Aided Drug Design. 15 (5): 605617.

2. Campaner E, Rustighi A, Zannini A, Cristiani A, Piazza S, Ciani Y, Kalid O, Golan G, Baloglu E, Shacham S, Valsasina B (August 2017). "A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action". Nature Communications. 8 (1): 15772. Bibcode:2017NatCo...815772C.

Details